Variant position: 391 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 524 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TLTVVTADHSHVFTFGGYTP RGNSIFGLAPMLSDTDKKPFT
Mouse TLTVVTADHSHVFTFGGYTP RGNSIFGLAPMVSDTDKKPFT
Rat TLTVVTADHSHVFTFGGYTP RGNSIFGLAPMVSDTDKKPFT
Bovine TLTVVTADHSHVFTFGGYTP RGNSIFGLAPMVSDTDKKPFT
Cat TLTIVTADHSHVFTFGGYTP RGNSIFGLAPMVSDTDKKPFT
Chicken TLSVVTADHSHVFTFGGYTP RGNPIFGLAPMQSDVDRKPFT
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
18 – 501 Alkaline phosphatase, tissue-nonspecific isozyme
378 – 378 Zinc 1
379 – 379 Zinc 1; via tele nitrogen
Mutational analysis and functional correlation with phenotype in German patients with childhood-type hypophosphatasia.
Orimo H.; Girschick H.J.; Goseki-Sone M.; Ito M.; Oda K.; Shimada T.;
J. Bone Miner. Res. 16:2313-2319(2001)
Cited for: INVOLVEMENT IN HOPSC; VARIANTS HOPSC MET-68; SER-71; THR-177; TRP-223; PRO-275 AND HIS-391; CHARACTERIZATION OF VARIANTS HOPSC MET-68; SER-71; THR-177; TRP-223; PRO-275 AND HIS-391; VARIANT ALA-522; CHARACTERIZATION OF VARIANT ALA-522;
Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.
Fauvert D.; Brun-Heath I.; Lia-Baldini A.S.; Bellazi L.; Taillandier A.; Serre J.L.; de Mazancourt P.; Mornet E.;
BMC Med. Genet. 10:51-51(2009)
Cited for: VARIANTS HOPS CYS-71; HIS-71; THR-111; THR-176; LYS-191; ARG-334; ASP-334; ARG-339; ILE-382; CYS-391; HIS-391; MET-414; ALA-420; LYS-452; LEU-459 AND ALA-476; CHARACTERIZATION OF VARIANTS HOPS CYS-71; HIS-71; THR-111; THR-176; LYS-191; ARG-334; ASP-334; ARG-339; ILE-382; CYS-391; HIS-391; MET-414; LYS-452; LEU-459 AND ALA-476;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.